Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Fluorouracil

Known as: 5-Fluracil, 5-Fluoro-2,4(1H,3H)-pyrimidinedione, Fluouracil 
An antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity. Fluorouracil and its metabolites possess a… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Importance Patients with locally advanced pancreatic cancer have historically poor outcomes. Evaluation of a total neoadjuvant… Expand
Review
2019
Review
2019
Tumor formation and growth depend on various biological metabolism processes that are distinctly different with normal tissues… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Review
2018
Review
2018
Resistance to therapeutic agents, either intrinsic or acquired, is currently a major problem in the treatment of cancers and… Expand
  • figure 1
  • table 1
  • figure 2
Review
2018
Review
2018
Transforming growth factor β (TGF-β) signaling pathway plays important roles in many biological processes, including cell growth… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Review
2018
Review
2018
Purpose In 2016, ASCO published a guideline to assist in clinical decision making in metastatic pancreatic cancer for initial… Expand
  • table 1
  • table 2
Review
2018
Review
2018
Colorectal cancer is the third most common cancer worldwide with a high mortality rate at the advanced stages. However… Expand
  • table 1
  • table 2
Review
2018
Review
2018
Fluoropyrimidines such as 5-fluorouracil (5-FU) form the foundation of a wide variety of chemotherapy regimens. 5-FU is in fact… Expand
  • table 1
  • table 1
  • figure 1
  • figure 2
  • table 2
Review
2018
Review
2018
The overall 5-year survival for pancreatic cancer has changed little over the past few decades, and pancreatic cancer is… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Review
2017
Review
2017
The objective of this systematic review was to provide current evidence regarding the use of adjuvant systemic chemotherapy for… Expand
Review
2017
Review
2017
Pancreatic ductal adenocarcinoma (PDAC), commonly referred to as pancreatic cancer, ranks among the leading causes of cancer… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3